A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis in Hong Kong. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council investigation.

Suppr

超能文献

出版信息

Tubercle. 1974 Mar;55(1):1-27. doi: 10.1016/0041-3879(74)90064-6.

DOI:10.1016/0041-3879(74)90064-6

PMID:4283482

Abstract

摘要

相似文献

A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis in Hong Kong. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council investigation.

Tubercle. 1974 Mar;55(1):1-27. doi: 10.1016/0041-3879(74)90064-6.

A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council Investigation.香港结核病治疗服务/布朗普顿医院/英国医学研究委员会调查

Tubercle. 1974 Mar;55(1):1-27.

Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Clinical observations on adverse reactions.香港治疗服务——皇家研究生医学院——英国医学研究理事会关于利福平加乙胺丁醇每日及间歇用药方案的合作研究。不良反应的临床观察。

Scand J Respir Dis Suppl. 1973;84:119-24.

Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong.香港肺结核每日及间歇利福平治疗方案的不良反应

Br Med J. 1972 Mar 25;1(5803):765-71. doi: 10.1136/bmj.1.5803.765.

[Clinical evaluation of rifampicin for pulmonary tuberculosis. 3. A controlled trial on the clinical effects of chemotherapy with rifampicin-ethambutol and viomycin-ethambutol in retreatment cases of pulmonary tuberculosis].

Kekkaku. 1971 Sep;46(9):371-7.

A comparative study of daily followed by twice or once weekly regimens of ethambutol and rifampicin in retreatment of patients with pulmonary tuberculosis. The results at 1 year. A cooperative tuberculosis chemotherapy study in Poland.

Tubercle. 1975 Mar;56(1):1-26. doi: 10.1016/0041-3879(75)90003-3.

Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment cases.利福平加异烟肼用于肺结核的初始治疗，利福平和乙胺丁醇用于复治病例。

Chest. 1972 Jun;61(6):579-82. doi: 10.1016/s0012-3692(15)39159-5.

A controlled trial of daily and intermittent rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis: results up to 30 months.利福平加乙胺丁醇每日用药与间歇用药治疗肺结核复治患者的对照试验：30个月的结果

Tubercle. 1975 Sep;56(3):179-89. doi: 10.1016/0041-3879(75)90050-1.

A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once-weekly regimen of chemotherapy. A Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation.小剂量利福平每日服用预防化疗每周一次方案中药物不良反应的对照临床试验。香港结核病防治服务机构-英国医学研究委员会调查。

Clin Allergy. 1974 Mar;4(1):1-12.

A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once-weekly regimen of chemotherapy in Hong Kong: second report:-the results at 12 months.香港一项关于小剂量利福平每日服用以预防每周一次化疗方案中该药物不良反应的对照临床试验：第二次报告——12个月时的结果

Tubercle. 1974 Sep;55(3):193-210. doi: 10.1016/0041-3879(74)90046-4.

引用本文的文献

Characteristics of and treatment outcomes in rifampicin-intolerant patients.利福平不耐受患者的特征及治疗结果

IJTLD Open. 2024 Apr 1;1(4):160-165. doi: 10.5588/ijtldopen.23.0466. eCollection 2024 Apr.

Four months of rifampicin monotherapy for latent tuberculosis infection in children.对儿童潜伏性结核感染进行四个月的利福平单药治疗。

Clin Exp Pediatr. 2022 May;65(5):214-221. doi: 10.3345/cep.2021.01186. Epub 2021 Oct 29.

Hypersensitivity reactions to non beta-lactam antimicrobial agents, a statement of the WAO special committee on drug allergy.世界变态反应组织药物过敏特别委员会关于非β-内酰胺类抗菌药物过敏反应的声明。

World Allergy Organ J. 2013 Oct 31;6(1):18. doi: 10.1186/1939-4551-6-18.

Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis.标准化治疗既往治疗和/或耐异烟肼单药的活动性肺结核患者：系统评价和荟萃分析。

PLoS Med. 2009 Sep;6(9):e1000150. doi: 10.1371/journal.pmed.1000150.

Drug-resistant tuberculosis.耐药结核病

CMAJ. 2000 Aug 22;163(4):425-8.

Fully intermittent dosing with drugs for tuberculosis.结核病药物的全间歇给药法。

Cochrane Database Syst Rev. 2000;2001(2):CD000970. doi: 10.1002/14651858.CD000970.

Epidemiology, control and treatment of multidrug-resistant tuberculosis.耐多药结核病的流行病学、控制与治疗

Drugs. 1996;52 Suppl 2:103-7; discussion 107-8. doi: 10.2165/00003495-199600522-00021.

Adverse effects of antituberculosis drugs.抗结核药物的不良反应。

Drugs. 1982 Jan-Feb;23(1-2):56-74. doi: 10.2165/00003495-198223010-00003.

Intermittent treatment regimens in pulmonary tuberculosis.肺结核的间歇治疗方案

Lung. 1979;156(1):17-32. doi: 10.1007/BF02713988.

Prospects of retreatment of chronic resistant pulmonary tuberculosis patients. A critical review.

Lung. 1977;154(2):91-102. doi: 10.1007/BF02713523.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验